By decorating cell surfaces with TRAIL, the delivery system harnesses active targeting via receptor–ligand interactions, ensuring high local concentrations of TRAIL at tumor sites while minimizing systemic exposure. This evidence concerns the gene TNFSF10 and neoplasm.